首页> 外文期刊>African Journal of Microbiology Research >Evaluation of antibacterial activity of some non-steroidal anti-inflammatory drugs againstEscherichia coli causing urinary tract infection
【24h】

Evaluation of antibacterial activity of some non-steroidal anti-inflammatory drugs againstEscherichia coli causing urinary tract infection

机译:评价一些非甾体类抗炎药对引起尿路感染的大肠杆菌的抗菌活性

获取原文
           

摘要

Extensive use of antibiotics for urinary tract infections has led to the emergence of drug-resistant microorganisms and one solution to this problem is to search for non-antibiotic compounds that exert anti-bacterial activity through different mechanisms such as non-steroidal anti-inflammatory drugs (NSAIDs). In this study, out of 100 urine samples; 48 Escherichia coli strains were detected, 47.9% were multi-drug resistant. The antibiogram resistance pattern of the strains was carried out by agar dilution method. Diclofenac sodium, indomethacin, aspirin and ibuprofen were tested against the E. coli isolates. Diclofenac sodium showed the lowest MIC50 and MIC90; 8 and 256 mg/ml, respectively. Aspirin showed MIC50 of 64 mg/ml, while both indomethacin and ibuprofen showed MIC50 of 256 mg/ml. Indomethacin, aspirin and ibuprofen showed the same MIC90 of 1024 mg/ml. The combined effects of the four NSAIDs and five antibiotics (Amoxicillin, Augmentin, Cefotaxime, Ciprofloxacin and Gentamicin) were tested on five resistant clinical E. coli strains by checkerboard dilution technique. All the tested NSAIDs significantly reduced the minimum inhibitory concentrations (MICs) of antibiotics against the tested bacteria and fractional inhibitory concentration indices (FICIs) for this combination ranged from 0.03 to 0.5. In this study, leakage of intracellular components suggests that the effect of NSAIDs on E. coli could be the formation of pores in the plasma membrane and scanning electron microscopy (SEM) observations confirmed the damage to the structural integrity of the tested bacteria. In conclusion, NSAIDs showed antibacterial activity against E. coli causing urinary tract infections (UTIs), a combination of them and antibiotics exhibited good synergism and the mechanism of their action was by damaging the bacterial cell membrane.
机译:尿路感染中广泛使用抗生素已导致耐药微生物的出现,解决此问题的一种方法是寻找通过不同机制发挥抗菌活性的非抗生素化合物,例如非甾体类抗炎药(NSAID)。在这项研究中,从100个尿液样本中检出48株大肠埃希菌,其中47.9%具有多重耐药性。通过琼脂稀释法进行菌株的抗菌谱抗性图。测试了双氯芬酸钠,消炎痛,阿司匹林和布洛芬对大肠杆菌的分离物。双氯芬酸钠显示最低的MIC50和MIC90;分别为8和256 mg / ml。阿司匹林的MIC50为64 mg / ml,消炎痛和布洛芬的MIC50为256 mg / ml。消炎痛,阿司匹林和布洛芬的MIC90均为1024 mg / ml。通过棋盘稀释技术,对五种耐药的临床大肠杆菌菌株测试了四种NSAID和五种抗生素(阿莫西林,奥金汀,头孢噻肟,环丙沙星和庆大霉素)的联合作用。所有测试的NSAID均显着降低了抗生素对测试细菌的最低抑菌浓度(MICs),该组合的抑菌分数浓度指数(FICI)为0.03至0.5。在这项研究中,细胞内成分的泄漏表明,NSAIDs对大肠杆菌的影响可能是在质膜上形成孔,而扫描电子显微镜(SEM)的观察证实了对受试细菌结构完整性的损害。总之,非甾体抗炎药对大肠杆菌引起的泌尿道感染(UTI)具有抗菌活性,它们与抗生素的组合具有良好的协同作用,其作用机理是通过破坏细菌细胞膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号